Nifty
Sensex
:
:
10678.95
35457.83
62.25 (0.59%)
197.29 (0.56%)

Pharmaceuticals & Drugs

Rating :
79/99

BSE: 506820 | NSE: ASTRAZEN

1687.60
-2.85 (-0.17%)
16-Nov-2018 | 10:44AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1700.60
  •  1700.60
  •  1670.20
  •  1690.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  15155
  •  255.76
  •  1960.00
  •  919.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,179.13
  • 497.87
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,053.20
  • N/A
  • 15.86

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 3.55%
  • 14.69%
  • FII
  • DII
  • Others
  • 0.06%
  • 5.44%
  • 1.26%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 3.80
  • 0.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 23.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 70.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 52.30
  • 84.44
  • 120.62

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.82
  • 16.38
  • 14.95

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 39.62
  • 48.13
  • 61.14

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update:


  • AstraZeneca Pharma receives marketing permission for Olaparib
    17th Aug 2018, 09:30 AM

    The receipt of this permission paves way for the launch of olaparib in India

    Read More
  • Astrazeneca Pharma I - Quarterly Results
    13th Aug 2018, 19:04 PM

    Read More
  • AstraZeneca Pharma receives marketing permission for Osimertinib
    9th Aug 2018, 11:07 AM

    The receipt of this permission paves way for the launch of osimertinib in India for 1st line treatment

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.